In the dynamic realm of cryptocurrencies, Cardano (ADA) has emerged as a leading layer-1 blockchain, renowned for its decentralized apps (DApps), decentralized finance (DeFi), and Web3 capabilities. Recently, an interesting stat has been observed in Cardano’s market – one-third of ADA holders are now in a profitable position. While this shows the resilience of a top altcoin like ADA, there’s a new ICO gaining significant traction in the presale phase: InQubeta (QUBE), along with an old horse, Injective (INJ).
InQubeta (QUBE): Pioneering the AI Investment Revolution
InQubeta has an innovative vision: to make investing in AI startups accessible to everyone, not just the big players with deep pockets. They want to level the playing field and guess what? They are just doing that with their QUBE token. This isn’t just another project; it’s a key that unlocks the door to investments in AI. With QUBE, anyone and everyone can get a piece of the action in the AI market. It’s a game-changer, making the world of AI investment an inclusive playground for all. Startups can issue some of the coolest NFTs representing their venture, while QUBE holders can invest in these and share profits made by the companies they support.
QUBE is not just another top crypto to invest in, it’s a gateway to exploring the exciting world of AI ventures. This ERC20 coin has a deflationary design, which is achieved through a burn tax on each transaction. Those who lock their assets can also benefit from a portion of each trade. This mechanism encourages community engagement, scripting a happy ending for every holder.
InQubeta’s smart contract, audited by Hacken and KYC verified by BlockAudit, ensures a secure investment option. Having raised over $5.5 million in the ongoing presale, the platform is gearing up for an amazing launch. Come 2024, and you will see InQubeta with its own DAO and Swap.
One out of three Cardano Holders In Profit
Cardano has seen a remarkable turnaround, with 33% of ADA holders now experiencing profits. This is a significant increase from the mere 5% “In the Money” reported earlier. Despite this, more than half of Cardano holders are still facing unrealized losses, with 60% considered “Out of the Money” and only 7% at breakeven.
The spike in the percentage of long-term holders who are “out of the money” suggests that these investors are less likely to sell their holdings. With fresh capital making its way into the market, the selling pressure is anticipated to be on the lower side, thus boosting the potential for ADA to rise further.
Injective Protocol – Blockchain for Finance
Injective is a specialized blockchain tailored for the finance sector. It’s an open and interoperable Layer-1 blockchain, crafted to support the future of DeFi applications. This includes decentralized trading platforms for spot and derivatives, prediction markets, and lending protocols. At the heart of Injective is the INJ token, with multiple use cases and high growth potential. It’s used in protocol governance, capturing value in decentralized apps (dApps), enhancing security through Proof of Stake (PoS), and for staking purposes.
Conclusion
The world of cryptocurrency is always buzzing with something new and exciting, and that’s exactly what we’re seeing with the latest happenings around Cardano and InQubeta. Cardano, a well-known name in the crypto space, is set to reward those who put faith in their ecosystem, while Injective Protocol is here to redefine decentralized trading. On the other side of the spectrum, we have InQubeta, a fresh face making waves in the world of AI investment. It’s exciting to see a new ICO step into the ring with such a unique focus, and it’s definitely shaking things up in the best way possible.
This diversity shows how crypto is a melting point of innovations and ideas. You have industry giants like Cardano still competing in the market to stay ahead, while new projects like InQubeta are charting their own path in the AI crypto merger.
Subscribe to our daily newsletter!
No spam, no lies, only insights. You can unsubscribe at any time.
